Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.
The prevalence of abnormal liver tests in people hospitalized with COVID-19 is higher than previously found.
People living with HIV are learning how to cope with a new pandemic.
HIV-positive people appear no more likely to contract the new coronavirus or to become seriously ill.
New database will collect information about cases of the novel coronavirus among people living with HIV.
Drugs used for decades to treat malaria may help people with the new coronavirus, but clinical trials are needed.
The protease inhibitor combination did not work significantly better than supportive care, though those treated earlier might benefit.
What’s more, reports that Kaletra can fight the novel coronavirus have not been confirmed.
One link between coronaviruses (COVID-19) and the HIV drug Kaletra dates back to the 2003 outbreak of SARS.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.